Adenoviral vector-mediated gene expression in the nervous system of immunocompetent Wistar and T cell-deficient nude rats: Preferential survival of transduced astroglial cells in nude rats

Human Gene Therapy

Volumn 8, Issue 9, 1997, Pages 1049-1063

  Hermens, Wim T J M C ^b   Verhaagen, Joost ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL INFILTRATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPRESSION VECTOR; FACIAL NERVE NUCLEUS; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; GLIA CELL; IMMUNE DEFICIENCY; MACROPHAGE; MALE; MOTONEURON; NERVOUS SYSTEM; NONHUMAN; RAT; T LYMPHOCYTE;

ADENOVIRIDAE; ANIMALIA; RATTUS NORVEGICUS;

EID: 0030739652     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.9-1049     Document Type: Article

References (79)

1. ADESANYA, M.R., REDMAN, R.S., BAUM, B.J., and O'CONNELL, B.C. (1996). Immediate inflammatory responses to adeno-mediated gene transfer in rat salivary glands. Hum. Gene Ther. 7, 1085-1093.
2. AKLI, S., CAILLAUD, C., VIGNE, E., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., and PESCHANSKI, M.R. (1993). Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3, 224-228.
3. ANGELOV, D.N., NESS, W.F., STREPPEL, M., ANDERMAHR, J., MADER, K., and STENNERT, E. (1996). Nimodipine accelerates axonal sprouting after surgical repair of rat facial nerve. J. Neurosci. 16, 1041-1048.
4. AMIN, R., WILMOTT, R., SCHWARTZ, Y., TRAPNELL, B., and STARK, J. (1995). Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vitro. Hum. Gene Ther. 6, 145-153.
5. ARMENTANO, D., SOOKDEO, C.C., HEHIR, K.M., GREGORY, R.J., ST. GEORGE, J.A., PRINCE, G.A., WADSWORTH, S.C., and SMITH, A.E. (1995). Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum. Gene Ther. 6, 1343-1353.
6. BAJOCCHI, G., FELDMAN, S.H., CRYSTAL, R.G., and MASTRANGELI, A. (1993). Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3, 229-234.
7. BERKNER, K.L. (1988). Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 6, 616-629.
8. BRIDEAU, R.J., CARTER, P.B., MCMASTER, W.R., MASON, D.W., and WILLIAMS, A.F. (1980). Two subsets of rat T lymhocytes defined with monoclonal antibodies. Eur. J. Immunol. 10, 609-615.
9. BRODY, S.L., METZGER, M., DANEL, C., ROSENFELD, M.A., and CRYSTAL, R.G. (1994). Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 821-836.
10. BYRNES, A.P., RUSBY, J.E., WOOD, M.J.A., and CHARLTON, H.M. (1995). Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66, 1015-1024.
11. BYRNES, A.P., MACLAREN, R.E., and CHARLTON, H.M. (1996a). Immunological instability of persistent adenovirus vectors in the brain: Peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination. J. Neurosci. 16, 3045-3055.
12. BYRNES, A.P., WOOD, M.J.A., and CHARLTON, H.M. (1996b). Role of T-cells in inflammation caused by adenovirus vectors in the brain. Gene Ther. 3, 644-651.
13. CAILLAUD, C., AKLI, S., VIGNE, E., KOULAKOFF, E., PERRICAUDET, M., POENARU, L., KAHN, L., and BERWALD-NETTER, Y. (1993). Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. Eur. J. Neurosci. 5, 1287-1291.
14. CAMMER, W., BLOOM, B.R., NORTON, W.T., and GORDON, S. (1978). Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination. Proc. Natl. Acad. Sci. USA 75, 1554-1558.
15. CANTRELL, D.A., ROBINS, R.A., BROOKS, C.G., and BALDWIN, R.W. (1982). Phenotype of rat natural killer cells defined by monoclonal antibodies marking rat lymphocyte subsets. Immunology 45, 97-103.
16. CORREALE, J., LI, S., WEINER, L.P., and GILMORE, W. (1995). Effect of persistent mouse hepatitis virus infection on MHC class I expression in murine astrocytes. J. Neurosci. Res. 40, 10-21.
17. DAI, Y., SCHWARTZ, E.M., GU, D., ZHANG, W., ZARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
18. DAVDISON, B.L., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M., and ROESSLER, B.J. (1993). A model system for in vivo gene transfer into the CNS using an adenoviral vector. Nature Genet. 3, 219-223.
19. DE JONG, WH., STEERENBERG, P.A., URSEM, P.S., OSTERHAUSER, A.D.M.E., VOS, J.G., and RUTTENBERG, E.J. (1980). The athymic nude rat, III. Natural cell-mediated cytotoxicity. Clin. Immunol. Immunopathol. 17, 163-172.
20. DION, L.D., FANG, J., and GARVER, R.I., JR. (1996). Supernatant rescue assay vs. polymerase chain reaction for detection of wild type adenovirus-contaminating recombinant adenovirus stocks. J. Virol. Meth. 56, 99-107.
21. DIJKSTRA, C.D., DÖPP, E.A., JOLING, P., and KRAAL, G. (1985). The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54, 589-599.
22. DURHAM, H.D., LOCHMÜLLER, H., JANI, A., ASCADI, G., MASSIE, B., and KARPATI, G. (1996). Toxicity of replication-defective adenoviral recombinants in dissociated cultures of nervous tissue. Exp. Neurol. 140, 14-20.
23. EGGERDING, F.A., and PIERCE, W.C. (1986). Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection. Virology 148, 97-113.
24. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2a in recombinant adenoviruses improves transgene expression and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
25. FALLAUX, F.J., KRANENBURG, O., CRAMER, S.J., HOUWELING, A., VAN ORMONDT, H., HOEBEN, R.C., and VAN DER EB, A.J. (1996). Characterization of 911: A new helper cell line for the titration and propagation of early-region-1-deleted adenoviral vectors. Hum. Gene Ther. 7, 215-222.
26. FEDEROFF, H., GESCHWIND, M.D., GELLER, A.I., and KESSLER, J.A. (1992). Expression of nerve growth factor in vivo, from a defective HSV-1 vector, prevents effects of axotomy on sympathetic ganglia. Proc. Natl. Acad. Sci. USA 89, 1636-1640.
27. FINIELS, F., GIMENEZ Y RIBOTTA, M., BARKATS, M., SAMOLYK, M., ROBERT, J., RIVAT, A., REVAH, F., and MALLET, J. (1995). Specific and efficient gene transfer strategy offers new potentialities for the treatment of motor neurone diseases. Neuroreport 7, 373-378.
28. FISCHER, K.J., CHOI, H., BURDA, J., CHEN, S., and J. WILSON (1996). Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217, 11-22.
29. FUKOMOTO, T., MCMASTER, W.R., and WILLIAMS, A.F. (1982). Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur. J. Immunol. 12, 237-243.
30. GESCHWIND M.D., HARTNICK, C.J., LIU, W., AMAT, J., VAN DE WATER, T.R., and FEDEROFF, H.J. (1996). Defective HSV-1 vector expressing BDNF in auditory ganguia elicits neurite outgrowth: Model for treatment of neuron loss following cochlear degeneration. Hum. Gene Ther. 20, 173-182.
31. GIGER, R.J., ZIEGLER, U., HERMENS, W.T.J.M.C., and SONDEREGGER, P. (1997). Adenovirus-mediated gene transfer in neurons: construction and characterization of a vector for heterologous expression of the axonal cell adhesion molecule axonin-1. J. Neurosci. Meth. 71, 99-112.
32. GIGER, R.J., WOLFER, D.P., DE WIT, M.J., and VERHAAGEN, J. (1996). Anatomy of rat semaphorin III/Collapsin-1 mRNA expression and relationship to developing nerve tracts during neuroembryogenesis. J. Comp. Neurol. 375, 378-392.
33. GINSBERG, H.S., HORSWOOD, R.L., CHANOCK, R.M., and PRINCE, G.A. (1990). Role of early genes in pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 87, 6191-6195.
34. GINSBERG, H.S., MOLDAWER, L.L., SEHGAL, P.B., REDINGTON, M., KILIAN, P.L., CHANOCK, R.M., and PRINCE, G.A. (1991). A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88, 1651-1655.
35. GILGENKRANTZ, H., DUBOC, D., JUILLARD, V., COUTON, D., PAVIRANI, A., GUILLET, J.G., BRIAND, P., and KAHN, A. (1995). Transient expression of genes in vivo into heart using first-generation adenoviral vectors: Role of the immune response. Gene Ther. 6, 1265-1274.
36. GORZIGLIA, M.I., KADA, M.D., YEI, S., LIN, J., LEE, G.M., LUTHRA, R., and TRAPNELL, B.C. (1996). Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol. 70, 4173-4178.
37. GRAHAM, F.L., and VAN DER EB, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
38. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vectors. Meth. Mol. Biol. 7, 109-128.
39. HERMENS, W.T.J.M.C., GIGER, R.J., HOLTMAAT, A.J.G.D., DIJKHUIZEN, P.A., HOUWELING, D.A., and VERHAAGEN, J. (1997). Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS. J. Neurosci. Meth. 71, 85-98.
40. HOLTMAAT, A.J.G.D., HERMENS, W.T.J.M.C., OBSTREICHER, A.B., GISPEN, W.H., KAPLITT, M.G., and VERHAAGEN, J. (1996). Efficient adenoviral vector directed expression of a foreign gene to neurons and sustentacular cells in the mouse olfactory neuroepithelium. Mol. Brain Res. 41, 148-156.
41. HÜNIG, T., WALLNY, H.J., HARTLEY, J.K., LAWERZKY, A., and TIEFENTHALER, G. (1989). A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J. Exp. Med. 169, 73-86.
42. JOLY, E., and OLDSTONE, M.B.A. (1992). Neuronal cells are deficient in loading peptides onto MHC class I molecules. Neuron 8, 1185-1190.
43. JONES, N., and SHENK, T. (1979). An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc. Natl. Acad. Sci. USA 76, 3665-3669.
44. KAPLITT, M.G., PFAUS, J.G., KLEOPOULOS, S.P., HANLON, B.A., RABKIN, S.D., and PFAFF, D.W. (1991). Expression of a functional foreign gene in adult mammalian brain following in vivo transfer via a herpes simplex virus type 1 defective viral vector. Mol. Cell. Neurosci. 2, 320-330.
45. KAPLITT, M.G., LEONE, P., SAMULSKI, R.J., XIAO, X., PFAFF, D.W., O'MALLEY, K.L., and DURING, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-154.
46. +T lymphocytes in intracellular microbial infections. Immunol. Today 9, 168-174.
47. LE GAL LA SALLE, G., ROBERT, J.J., BERRARD, S., RIDOUX, V., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., and MALLET, J. (1993). An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990.
48. LEVINE, A.J., and GINSBERG, H.S. (1968). Role of adenovirus structural proteins in the cessation of host-cell biosynthetic functions. J. Virol. 2, 430-439.
49. LI, T., ADAMIAN, M., ROOF, D.J., BERSON, E.L., DRYJA, T.P., ROESSLER, B.J., and DAVIDSON, B.L. (1994). In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest. Ophth. Vis. Sci. 35, 2543-2549.
50. LISOVOSKI, F., CADUSSAU, J., AKLI, S., CAILLAUD, C., VIGNE, E., POENARU, L., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., KAHN, A., and PESCHANSKI, M. (1994). In vivo transfer of a marker gene to study motoneuronal development. Neuroreport 5, 1069-1072.
51. LOCHMÜLLER, H., JANI, A., HUARD, J., PRESCOTT, S., SINIONEAU, M., MASSIE, B., KARPATI, G., and ACSADI, G. (1994). Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (dE1 + dE3) during passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
52. MCCOWN, T.J., XIAO, X., LI, J., BREESE, G.R., and SAMULSKI, R.J. (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713, 99-107.
53. MCCOY, R.D., DAVIDSON, B.L., ROESLER, B.J., HUFFNAGLE, G.B., JANICH, S.L., LAING, T.J., and SIMON, R.H. (1995). Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6, 1553-1560.
54. MÜLLBACHER, A., BELLETT, A.J.D., and HLA, R.T. (1989). The murine cellular immune response to adenovirus type 5. Immunol. Cell Biol. 67, 31-39.
55. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
56. PAXINOS, G., and WATSON, C. (1982). The Rat Brain in Stereotaxic Coordinates. (Academic Press, London).
57. PELTÉKIAN, E., PARRISH, E., BOUCHARD, C., PESCHANSKI, M., and LISOVOSKI, F. (1997). Adenovirus-mediated gene transfer to the brain: Methodological assessment. J. Neurosci. Meth. 71, 77-84.
58. PERRY, V.H., BELL, M.D., BROWN, H.C., and MATYSZAK, M.K. (1995). Inflammation in the nervous system. Curr. Opin. Neurobiol. 5, 636-641.
59. PRINCE, G.A., PORTER, D.D., JENSON, A.B., HORSWOOD, R.L., CHANOCK, R.M., and GINSBERG, H.S. (1993). Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J. Virol. 67, 101-111.
60. SHENK, T., JONES, N., COLBY, W., and FOWLKES, D. (1979). Functional analysis of adenovirus type 5 host-range deletion mutants defective for transformation of rat embryo cells. Cold Spring Harbor Symp. Quant. Biol. 44, 367-375.
61. SIMON, R.H., ENGELHARDT, J.F., YANG, Y., ZEPEDA, M., WEBER-PENDELTON, S., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to the lung of nonhuman primates: toxicity study. Hum. Gene Ther. 4, 771-780.
62. SUBRAMANIAN, T., POLLACK, I.F., and LUND, R.D. (1995). Rejection of mesencephalic retinal xenografts in the rat induced by systemic administration of recombinant interferon-gamma. Exp. Neurol. 131, 157-162.
63. ULENKATE, H.J.L.M., GISPEN, W.H., and JENNEKENS, F.G.I. (1995). No evidence for enhancement of recovery from a crush lesion of a motor nerve in rats by Org2766. Res. Neurol. Neurosci. 85-91.
64. VALENTINE, R.C., and PEREIRA, H.G. (1965). Antigens and structure of the adenovirus. J. Mol. Biol. 13, 13-20.
65. VERHAAGEN, J., HERMENS, W.T.J.M.C., OESTREICHER, A.B., GISPEN, W.H., RABKIN, S.D., PFAFF, D.W., and KAPLITT, M.G. (1994). Expression of the growth-associated protein B-50/GAP-43 via a defective herpes-simplex virus vector results in profound morphological changes in non-neuronal cells. Molec. Brain Res. 26, 26-36.
66. VERHAAGEN, J., HERMENS, W.T.J.M.C., HOLTMAAT, A.J.G.D., OESTREICHER, A.B., GISPEN, W.H., and KAPLITT, M.G. (1995). Viral vector-mediated gene transfer in the nervous system: Application to the reconstruction of neural circuits in the injured mammalian brain. In Viral Vectors, Gene Therapy and Neuroscience Applications. M.G. Kaplitt and A.D. Loewy, eds. (Academic Press, New York) pp. 119-138.
67. VOGT, L., GIGER, R.J., ZIEGLER, U., KUNZ, B., BUCHSTALLER, A., HERMENS, W.T.J.M.C., KAPLITT, M.G., ROSENFELD, M.R., PFAFF, D.W., VERHAGGEN, J., and SONDEREGGER, P. (1996). Continuous renewal of the axonal pathway sensor apparatus by insertion of new sensor molecules into the growth cone membrane. Curr. Biol. 6, 1153-1158.
68. VOS, J.G., BERKVENS, J.M., and KRUIJT, B.C. (1980a). The athymic nude rat, I. Morphology of lymphoid and endocrine organs. Clin. Immunol. Immunopath. 15, 213-228.
69. VOS, J.G., KREEFTENBERG, J.G., KRUIJT, B.C., KRUIZINGA, W., and STEERENBERG, P. (1980b). The athymic nude rat, II. Immunological characteristics. Clin. Immunol. Immunopath. 15, 229-237.
70. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994a). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
71. YANG, Y., NUNES, F.A., BERENCSI, K., GONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994b). Inactivation of E2a in recombinant adenoviruses limits cellular immunity and improves the prospect for gene therapy of cystic fibrosis. Nature Genet. 7, 362-369.
72. YANG, Y., ERTL, H.C.J., and WILSON, J.M. (1994c). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1, 433-442.
73. YANG, Y., LI, Q., ERTL, H.C., and WILSON, J.M. (1995a). Cellular and humoral immune response to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
74. YANG, Y., TRINCHIERI, G., and WILSON, J.M. (1995b). Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med. 1, 890-893.
75. YEH, P., DEDIEU, J., ORSINI, S., VIGNE, E., DENEFLE, P., and PERRICAUDET, M. (1996). Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J. Virol. 70, 559-565.
76. YEI, S., MITTEREDER, N., WERT, S., WHITSETT, J.A., WILMOTT, R.W., and TRAPNELL, B.C. (1994). In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum. Gene Ther. 5, 731-744.
77. ZHANG, W.W., PATRICIA, E., KOCH, P.E., and ROTH, J.A. (1995). Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. BioTechniques 18, 444-447.
78. ZHANG, Y., and SCHNEIDER, R.J. (1994). Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J. Virol. 68, 2544-2555.
79. ZSENGELLER, Z.K., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1995). Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6, 457-467.